Back to ADXS Stock Lookup

Advaxis (ADXS) – StreetInsider.com Reports

Aug 26, 2021 06:26 AM Advaxis (ADXS) Climbs 25% Pre-Open
Jul 6, 2021 09:30 AM Pre-Open Stock Movers 07/06: (ADXS) (AXLA) (WB) Higher; (PRVB) (DIDI) (LLNW) Lower (more...)
Jul 6, 2021 06:43 AM Advaxis (ADXS) and Biosight Announce Entry into Definitive Merger Agreement
May 20, 2021 09:26 AM Pre-Open Stock Movers 05/20: (SPCE) (VTGN) (PLCE) Higher; (BDTX) (RIDE) (BJ) Lower (more...)
Apr 12, 2021 08:32 AM Advaxis (ADXS) Prices $20M Share Registered Direct Offering
Apr 5, 2021 08:03 AM Advaxis (ADXS) Announces Agreement with Columbia University Irving Medical Center to Fund Phase 1 Study of ADXS-504 for the Treatment of Early Prostate Cancer
Jan 19, 2021 08:11 AM Advaxis (ADXS) Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies
Nov 24, 2020 08:33 AM Advaxis (ADXS) Announces Pricing of $8 Million Public Offering of Common Stock, Warrants
Nov 23, 2020 05:23 PM After-Hours Stock Movers 11/23: (CANG) (APYX) (ALT) Higher; (ADXS) (TELA) (BLDP) Lower (more...)
Nov 23, 2020 04:09 PM Advaxis (ADXS) to Offer Common Stock
Oct 26, 2020 08:06 AM Advaxis' (ADXS) ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial
Sep 29, 2020 08:33 AM Advaxis (ADXS) Adopts Limited Duration Stockholder Rights Plan
Sep 24, 2020 08:02 AM Advaxis (ADXS) Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer
Sep 4, 2020 04:30 PM Advaxis (ADXS) Announces Resignation of CFO
Aug 3, 2020 08:04 AM Advaxis (ADXS) Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital
Feb 27, 2020 09:05 AM Advaxis (ADXS) Reports Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Feb 20, 2020 08:14 AM Advaxis (ADXS) Reports Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Feb 13, 2020 08:10 AM Advaxis (ADXS) Announces Updated Survival Data in Phase 1/2 ADXS-PSA Trial at ASCO
Feb 11, 2020 09:22 AM Pre-Open Stock Movers 02/11: (S) (AMKR) (TMUS) Higher; (YAYO) (CODX) (UAA) Lower (more...)
Feb 11, 2020 09:13 AM Advaxis (ADXS) Gains 8% on Agreement with Personalis for ADXS-503 Trial
Jan 21, 2020 08:32 AM Advaxis (ADXS) Prices 10M Share Registered Direct Offering at $1.05/Sh
Jan 7, 2020 08:02 AM Advaxis (ADXS) Announces FDA Clearance of IND for ADXS-504 for Treatment of Prostate Cancer
Dec 3, 2019 08:02 AM Advaxis (ADXS) Reports Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer
Oct 10, 2019 08:09 AM Advaxis (ADXS), UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Oct 7, 2019 08:02 AM Advaxis (ADXS) Reports Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
Aug 22, 2019 08:05 AM Advaxis (ADXS) Issues Shareholder Letter
Jul 23, 2019 08:34 AM Advaxis (ADXS) Prices $16 Million Public Offering of Common Stock, Warrants
Jul 15, 2019 08:02 AM Advaxis (ADXS) Reports New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies
Jun 27, 2019 06:53 AM Advaxis (ADXS) Announces Increasing Focus on Neoantigen-Directed Immunotherapies, Reports Closing of Its Phase 3 AIM2CERV Study
May 15, 2019 08:21 AM Advaxis (ADXS) to Resume Trading at 8:30 am ET
May 15, 2019 08:03 AM Advaxis (ADXS) Announces FDA Lifts Partial Clinical Hold on Phase 3 AIM2CERV Study of Axalimogene Filolisbac
May 15, 2019 07:55 AM Advaxis (ADXS) Halted, News Pending
Apr 3, 2019 09:20 AM Pre-Open Stock Movers 04/03: (APRN) (I) (PLAY) Higher; (FSNN) (AVEO) (GME) Lower (more...)
Apr 3, 2019 07:31 AM Advaxis (ADXS) Prices 2.5M Share Common Stock Offering at $4/Each
Apr 2, 2019 05:58 PM After-Hours Movers 04/02: (APRN) (PLAY) (AABA) Higher; (ADXS) (USNA) (GME) (more...)
Apr 2, 2019 04:06 PM Advaxis (ADXS) Announces Proposed Common Offering
Apr 1, 2019 08:03 AM Advaxis (ADXS) ADXS-PSA in Combination with KEYTRUDA Prolonged Survival in mCRPC
Mar 29, 2019 03:01 PM Advaxis (ADXS) Preliminary Data from Phase 1 Study Evaluating ADXS-NEO Suggest Rapid Immunogenicity and Clinical Activity
Mar 28, 2019 01:03 PM Advaxis (ADXS) Reports 1-for-15 Reverse Share Split
Mar 25, 2019 08:04 AM Advaxis (ADXS) Granted U.S. Patent Relating to Axalimogene Filolisbac
Mar 20, 2019 02:25 AM Advaxis (ADXS) PT Lowered to $0.40 at Jefferies
Mar 12, 2019 08:06 AM Advaxis (ADXS) Reports Q1 EPS of $0.18
Feb 14, 2019 08:31 AM Advaxis (ADXS) Reports First Patient Enrollment in Phase 1/2 Trial for ADXS-HOT in the Treatment of NSCLC
Jan 23, 2019 04:07 PM Advaxis (ADXS) Says Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests ADXS: Advaxis
Jan 23, 2019 04:01 PM Advaxis (ADXS) Halted, News Pending
Dec 18, 2018 07:34 AM UPDATE: H.C. Wainwright Downgrades Advaxis (ADXS) to Neutral
Dec 17, 2018 10:17 AM Advaxis (ADXS) PT Lowered to $3 at Euro Pacific Capital
Nov 2, 2018 08:04 AM Advaxis (ADXS) Announces Update on Clinical Pipeline
Sep 18, 2018 06:15 AM Euro Pacific Capital Starts Advaxis (ADXS) at Buy
Sep 7, 2018 09:26 AM Advaxis (ADXS) Prices 16.67M Shares Offering

Back to ADXS Stock Lookup